Breast Cancer Xenograft Models Available

Breast cancer xenograft models

Several PDTX breast tumor models are available representing the following tumor types:

Request breast cancer xenograft study quotation from Altogen Labs CRO.

TNBCs are negative for estrogen receptor, progesterone receptor and HER2 overexpression.

The TNBC tumor type is observed in 10-17% of all breast carcinomas, however, it is responsible for a relatively large proportion of deaths. Patients diagnosed with TNBC have an increased likelihood of distant recurrence, partial response to chemotherapy and poor overall survival.

Treatment options are limited for patients with TNBCs making testing of novel therapeutic strategies a high priority.

There are nine TNBC models available for this critical area of research.

Request formal xenograft breast cancer project quotation from Altogen Labs CRO.